Stef Flavin serves as the HR Business Lead for Research & Development at Biogen, where she plays a pivotal role in aligning human resources strategies with the organization’s mission to advance innovative therapies for neurological diseases. With extensive experience in the biotechnology sector, Stef has...
Stef Flavin serves as the HR Business Lead for Research & Development at Biogen, where she plays a pivotal role in aligning human resources strategies with the organization’s mission to advance innovative therapies for neurological diseases. With extensive experience in the biotechnology sector, Stef has developed a robust understanding of the unique challenges and opportunities that come with managing talent in a fast-paced, highly regulated environment. Her expertise spans across various domains, including clinical research, clinical trials, and regulatory compliance, making her an invaluable asset to Biogen's strategic initiatives.
In her current role, Stef is instrumental in driving key projects that enhance workforce engagement and optimize talent acquisition for the US Commercial MS Franchise, Market Access & Reimbursement, and US Commercial Strategic Operations. She leverages her deep knowledge of FDA regulations, Good Manufacturing Practices (GMP), and Good Clinical Practices (GxP) to ensure that Biogen not only attracts top talent but also fosters a culture of compliance and excellence. Stef’s proficiency in data management and software documentation further supports her efforts in streamlining HR processes and improving operational efficiencies.
Her collaborative approach enables her to work closely with cross-functional teams, ensuring that HR strategies are effectively integrated into the broader business objectives. By focusing on staffing services tailored to the needs of clinical research and development, Stef is committed to building a diverse and skilled workforce that drives Biogen’s mission forward. Her passion for the biotechnology industry and dedication to employee development make her a key leader in shaping the future of Biogen’s R&D initiatives.
